Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

62FB05A13F2521678725830C0063A368 Hearing Summary




PUBLIC
BILL SUMMARY For PUBLIC COMMENT

INTERIM COMMITTEE  OPIOID AND OTHER SUBSTANCE USE DISORDERS
Date Sep 18, 2018      
Location HCR 0112



Public Comment - Committee Discussion Only


12:08:21 PM  

Representative Pettersen proceeded with public comment.

12:08:40 PM  

Lauren Snyder, Mental Health Colorado, testified regarding draft bill #1.  Ms. Snyder responded to committee questions.

12:12:14 PM  

Frank Cornelia, Colorado Behavioral Healthcare Council, testified regarding draft bill #1.  Mr. Cornelia responded to committee questions.

12:21:34 PM  

Lisa Pearson, representing herself, testified regarding draft bill #3 on harm reduction.

12:24:24 PM  

Angela Bonaguidi, Colorado Organization for the Treatment of Opioid Dependence, testified regarding reimbursements for SUD treatment providers and distributed a handout (Attachment D).  Ms. Bonaguidi responded to committee questions.

12:29:50 PM  

Denise Vincioni, Colorado Organization for the Treatment of Opioid Dependence, testified regarding SUD treatment providers.  Ms. Vincioni responded to committee questions.

12:34:32 PM  

Anna Warrener, representing herself, testified regarding her father's experience with chronic pain.  Ms. Warrener responded to committee questions.

12:44:42 PM  

Dr. Jonathan Clapp, Colorado Pain Society, testified regarding insurance policies and opioid medication.  Dr. Clapp responded to committee questions.

12:50:58 PM  

Suzanne Hamilton, Colorado Chapter - American College of Emergency Physicians, testified regarding electronic prescribing.  Ms. Hamilton responded to committee questions.






The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details